Talis Biomedical Corporation (TLIS)
OTCMKTS
· Delayed Price · Currency is USD
1.700
0.00 (0.00%)
Dec 27, 2024, 9:50 AM EST
Talis Biomedical Company Description
Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States.
Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.
Talis Biomedical Corporation
| Country | United States |
| Founded | 2013 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 99 |
| CEO | Robert Kelley |
Contact Details
Address: 1375 West Fulton Market Chicago, Delaware 60607 United States | |
| Phone | 650 433 3000 |
| Website | talisbio.com |
Stock Details
| Ticker Symbol | TLIS |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US87424L1089 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Robert Kelley MBA | Chief Executive Officer and Director |
| Rebecca Markovich | Interim Chief Financial Officer |
| Liang Li Ph.D. | Co-Founder and Director of Technology and Strategy |
| Jill Green | Senior Vice President of Legal |
| Margaret Barrett M.S. | Controller |
| Gillian Green | Company Secretary |